Prognostic biomarkers are key to the treatment of patients with CC and the decision to recommend adjuvant chemotherapy in patients with early-stage disease.18 At present, tumor grade, TNM stage and patient gender remain the most important among a handful of prognostic variables that are considered in the development of algorithms for the treatment of patients with early-stage CC.19, 20 In this study, we analyzed the relationship between NCAPH expression, and the pathogenesis and prognosis of CC. Here, NCAPH is linked to neoplasm.